Literature DB >> 6969113

T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients.

P A Kaszubowski, G Husby, K S Tung, R C Williams.   

Abstract

Patients with cancer often show impaired immune functions; however, the basis of this suppression is still not understood. In several experimental systems, human T-cells with receptors for Fc of immunoglobulin G may function as suppressors, and those with receptors for Fc of immunoglobulin M may function as helpers. Peripheral blood as well as tumor tissue infiltrates were examined for proportions and numbers of T gamma, T mu, or Ia-positive T-cells. Forty-five untreated patients with solid tumors and 24 patients with lymphomas were studied. An increase in the percentage of peripheral blood T gamma cells (p < 0.001) and a decrease in T mu cells (p < 0.0005) were recorded in all tumor patients when compared with 30 normal controls. Percentages and absolute numbers of peripheral blood Ia-positive T-cells were decreased (p < 0.001 and < 0.00001) in solid-tumor patients; by contrast, the proportion of peripheral blood Ia-positive T-cells was elevated (p < 0.005) in lymphoma subjects. Studies of cancer tissues from 46 untreated patients using immunofluorescence and mouse hybridoma antibody specific for T-cells showed that tumor lymphocytic infiltrates were composed mainly of T-cells. Double staining with fluorescein-conjugated specific anti-T gamma and Ia-positive T-cells within solid-tumor lymphoid infiltrates. A comparison of peripheral blood and tumor lymphocyte T-cell profiles revealed that, in some patients, low proportions of Ia-positive T-cells in blood were paralleled by a high percentage of such cells in tumor lymphoid infiltrates.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969113

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer.

Authors:  R Bilik; C Mor; B Hazaz; C Moroz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions.

Authors:  F Indiveri; I Pierri; S Rogna; A Poggi; R Romano; A Tavano; G Ratto; G Motta; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Human T-lymphocyte subset production of immune (gamma) interferon.

Authors:  L B Epstein; S Gupta
Journal:  J Clin Immunol       Date:  1981-07       Impact factor: 8.317

4.  Studies on the lymphocytic subpopulations in acute non-lymphocytic leukemia.

Authors:  M X Zhou; L Y Wang; G X Shen; G Z Liu
Journal:  Acta Acad Med Wuhan       Date:  1984

5.  Monoclonal antibodies to human T lymphocyte surface antigens: their potential application to urology.

Authors:  A W Ritchie; K James; G D Chisholm
Journal:  Urol Res       Date:  1982

6.  An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

Authors:  P K Lala; I F McKenzie
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

7.  Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study.

Authors:  A Balsari; R Marolda; C Gambacorti-Passerini; G Sciorelli; G Tona; E Cosulich; D Taramelli; G Fossati; G Parmiani; N Cascinelli
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.

Authors:  S Poppema; E B Bröcker; L de Leij; D Terbrack; T Visscher; A Ter Haar; E Macher; T H Thé; C Sorg
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.